CIK 0001041024 · Non-accelerated filer<br>Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383317208
- Phone
- 8004493353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Neri Jesse SVP, FINANCE AND CFO | Sale 10b5-1 | −886 | $1.10 | $975 | 30,000 |
| 2025-04-01 | Chole Timothy SVP, Chief Commercial Officer | Sale 10b5-1 | −2,868 | $1.08 | $3K | 46,035 |
| 2025-03-17 | Chole Timothy SVP, Chief Commercial Officer | Shares withheld for taxes | −2,823 | $1.77 | $5K | 48,903 |
| 2025-03-17 | TIMMINS MEGAN C. EVP, CLO and Secretary | Shares withheld for taxes | −3,137 | $1.77 | $6K | 68,575 |
| 2025-03-17 | Strobeck Mark President and CEO | Shares withheld for taxes | −6,101 | $1.77 | $11K | 131,604 |
| 2025-03-14 | Chole Timothy SVP, Chief Commercial Officer | Shares withheld for taxes | −2,444 | $1.70 | $4K | 51,726 |
| 2025-03-14 | Neri Jesse SVP, FINANCE AND CFO | Shares withheld for taxes | −2,444 | $1.70 | $4K | 30,886 |
| 2025-03-14 | TIMMINS MEGAN C. EVP, CLO and Secretary | Shares withheld for taxes | −3,666 | $1.70 | $6K | 71,712 |
| 2025-03-14 | Strobeck Mark President and CEO | Shares withheld for taxes | −7,333 | $1.70 | $12K | 137,705 |
| 2025-01-02 | Chole Timothy SVP, Chief Commercial Officer | Sale 10b5-1 | −1,001 | $2.05 | $2K | 54,170 |
| 2025-01-02 | Strobeck Mark President and CEO | Sale 10b5-1 | −2,163 | $2.06 | $4K | 145,038 |
| 2024-11-15 | RAVICH MARK H Director | Sale | −10,000 | $2.40 | $24K | 121,429 |
| 2024-11-15 | RAVICH MARK H Director | Sale | −19,991 | $2.32 | $46K | 0 |
| 2024-10-01 | Chole Timothy SVP, Chief Commercial Officer | Sale 10b5-1 | −1,001 | $3.69 | $4K | 55,171 |
| 2024-10-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −2,163 | $3.69 | $8K | 147,201 |
| 2024-05-21 | Radie Robert S Director | Grant or award | +36,111 | 93,525 | ||
| 2024-05-21 | RAVICH MARK H Director | Grant or award | +36,111 | 108,831 | ||
| 2024-05-21 | Lau Joan Director | Grant or award | +36,111 | 63,111 | ||
| 2024-05-21 | COOPER JOHN G Director | Grant or award | +36,111 | 95,451 | ||
| 2024-05-21 | Smiley Andrea Heslin Director | Grant or award | +36,111 | 92,062 |
Page 5 of 8 · 153 trades